Unleashing unconventional antigens for cancer immunotherapy

The Enara Bio™ purpose

Shining a light on Dark Antigen™ and T-cell biology to enable people to live free from the shadow of cancer. Our mission is to exploit previously uncharted genomic dark matter to develop cancer immunotherapies designed to provide lasting benefit for broad patient populations.

To achieve our mission, we have built an innovative technology platform called EDAPT™, which integrates bioinformatics, immunopeptidomics, target validation and immunology. The EDAPT platform enables us to discover a novel and differentiated class of cancer-specific targets from the genomic dark matter, which we call Dark Antigens. Our growing team has the depth of expertise and breadth of experience to advance this exciting area of immuno-oncology into novel therapeutics to benefit broad groups of cancer patients and their families.

Read more about us

Who we are

We are a diverse, experienced, and rapidly growing team driven by a common purpose and united by our shared values. The culture we have developed enables each of us to make an impact and deliver on our vision.

Introducing Enara Bio Poster

Latest News